Ardea Biosciences, Inc. (RDEA) Misses Q1 Views
Ardea Biosciences, Inc. (Nasdaq: RDEA) reported Q1 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $3.86 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AbbVie (ABBV) Tops Q4 EPS by 3c, Confirms Guidance
- Tyco International (TYC) Reports In-Line Q1 EPS; Lowers FY15 EPS Outlook
- Ingredion (INGR) Misses Q4 EPS Views; Issues Light FY15 EPS Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!